Matthias Villalobos

1.4k total citations · 1 hit paper
50 papers, 899 citations indexed

About

Matthias Villalobos is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Matthias Villalobos has authored 50 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Public Health, Environmental and Occupational Health, 22 papers in Oncology and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Matthias Villalobos's work include Palliative Care and End-of-Life Issues (25 papers), Childhood Cancer Survivors' Quality of Life (12 papers) and Cancer survivorship and care (12 papers). Matthias Villalobos is often cited by papers focused on Palliative Care and End-of-Life Issues (25 papers), Childhood Cancer Survivors' Quality of Life (12 papers) and Cancer survivorship and care (12 papers). Matthias Villalobos collaborates with scholars based in Germany, United States and Switzerland. Matthias Villalobos's co-authors include Michael Thomas, Mechthild Hartmann, Markus W. Haun, Gerta Rücker, Hans-Christoph Friederich, Katja Krug, Michel Wensing, Corinna Jung, Halina Sklenarova and Manfred Hensel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cochrane Database of Systematic Reviews.

In The Last Decade

Matthias Villalobos

44 papers receiving 882 citations

Hit Papers

Early palliative care for adults with advanced cancer 2017 2026 2020 2023 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Villalobos Germany 13 550 427 296 159 111 50 899
Paola Friedrich United States 13 636 1.2× 333 0.8× 792 2.7× 117 0.7× 108 1.0× 44 1.2k
Angela M. Feraco United States 11 279 0.5× 181 0.4× 188 0.6× 146 0.9× 210 1.9× 23 842
Federico Antillón United States 15 531 1.0× 211 0.5× 591 2.0× 75 0.5× 75 0.7× 26 858
Oreofe O. Odejide United States 18 619 1.1× 474 1.1× 492 1.7× 84 0.5× 36 0.3× 64 978
Jennifer Shin United States 15 279 0.5× 326 0.8× 232 0.8× 84 0.5× 296 2.7× 31 823
Monika Sztankay Austria 16 150 0.3× 395 0.9× 149 0.5× 94 0.6× 121 1.1× 50 648
Amirrtha Srikanthan Canada 17 344 0.6× 235 0.6× 306 1.0× 105 0.7× 115 1.0× 62 842
Maria Theresa Redaniel United Kingdom 19 194 0.4× 387 0.9× 122 0.4× 81 0.5× 111 1.0× 66 941
Miguel Bonilla United States 21 785 1.4× 327 0.8× 809 2.7× 60 0.4× 63 0.6× 38 1.2k
Elena Springall Canada 7 263 0.5× 411 1.0× 93 0.3× 184 1.2× 182 1.6× 11 1.0k

Countries citing papers authored by Matthias Villalobos

Since Specialization
Citations

This map shows the geographic impact of Matthias Villalobos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Villalobos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Villalobos more than expected).

Fields of papers citing papers by Matthias Villalobos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Villalobos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Villalobos. The network helps show where Matthias Villalobos may publish in the future.

Co-authorship network of co-authors of Matthias Villalobos

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Villalobos. A scholar is included among the top collaborators of Matthias Villalobos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Villalobos. Matthias Villalobos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Thomas, Michael G., et al.. (2025). Web-based educational tools and decision aids for patients with advanced cancer: A systematic review. Patient Education and Counseling. 134. 108706–108706.
3.
Thomas, Michael L., et al.. (2024). Personal Values, Wishes, and Goals of Patients with Advanced Lung Cancer: A Qualitative Study. European Journal of Cancer Care. 2024(1).
4.
5.
Benze, Gesine, et al.. (2024). SOP – Übelkeit und Erbrechen bei Palliativpatient:innen Version II. GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen). 30(4). 312–318.
6.
Krisam, Johannes, et al.. (2023). HELP — Heidelberg decision aid for lung cancer patients: a randomized controlled clinical trial. Trials. 24(1). 356–356. 1 indexed citations
7.
Krug, Katja, et al.. (2022). Factors related to implementation of an interprofessional communication concept in thoracic oncology: a mixed-methods study. BMC Palliative Care. 21(1). 89–89. 2 indexed citations
8.
Krug, Katja, Johannes Krisam, Matthias Villalobos, et al.. (2021). Effects of an Interprofessional Communication Approach on Support Needs, Quality of Life, and Mood of Patients with Advanced Lung Cancer: A Randomized Trial. The Oncologist. 26(8). e1445–e1459. 17 indexed citations
9.
Ludwig, Marion, Jan Koetsenruijter, Katja Krug, et al.. (2021). Lung cancer patients’ comorbidities and attendance of German ambulatory physicians in a 5-year cross-sectional study. npj Primary Care Respiratory Medicine. 31(1). 2–2. 5 indexed citations
10.
Jung, Corinna, et al.. (2021). Developing a question prompt list for the oncology setting: A scoping review. Patient Education and Counseling. 105(7). 1689–1702. 4 indexed citations
12.
Muntañola, Ana, Tycho Baumann, A Caballero, et al.. (2020). Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group. Annals of Hematology. 99(7). 1627–1634. 3 indexed citations
13.
Villalobos, Matthias, et al.. (2019). Communication along Milestones in Lung Cancer Patients with Advanced Disease. Oncology Research and Treatment. 42(1-2). 41–46. 15 indexed citations
14.
Laryionava, Katsiaryna, Mechthild Hartmann, Halina Sklenarova, et al.. (2019). Cancer Patients’ Preferences for either Quality of Life or a Longer Life Determine Their Willingness to Talk about Forgoing Cancer-Specific Treatment. Oncology Research and Treatment. 42(9). 458–465. 5 indexed citations
15.
Villalobos, Matthias, Violet Handtke, Corinna Jung, et al.. (2019). HeiMeKOM (Heidelberger Meilenstein Kommunikation): Entwicklung einer interprofessionellen Intervention zur Verbesserung der Kommunikation bei Patient*innen mit eingeschränkter Prognose. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 147-148. 28–33. 4 indexed citations
16.
Villalobos, Matthias, Katja Krug, Johannes Krisam, et al.. (2018). The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial. Trials. 19(1). 438–438. 19 indexed citations
17.
Haun, Markus W., Gerta Rücker, Hans-Christoph Friederich, et al.. (2017). Early palliative care for adults with advanced cancer. Cochrane Database of Systematic Reviews. 2017(6). CD011129–CD011129. 479 indexed citations breakdown →
18.
Villalobos, Matthias, Katja Krug, Martina Kamradt, et al.. (2017). Reflection of illness and strategies for handling advanced lung cancer – a qualitative analysis in patients and their relatives. BMC Health Services Research. 17(1). 173–173. 10 indexed citations
19.
Rudofsky, Gottfried, Matthias Villalobos, Ruediger Waldherr, et al.. (2010). The Case ∣ Renal failure in a male with Waldenström's macroglobulinemia. Kidney International. 77(4). 371–372. 7 indexed citations
20.
Hensel, M., Fatime Krasniqi, Matthias Villalobos, Martin Kornacker, & Anthony D. Ho. (2004). Pentostatin, cyclophosphamide and rituximab is an active regimen with low toxicity for previously treated patients with B-cell chronic lymphocytic leukemia and Waldenström's macroglobulinemia. Journal of Clinical Oncology. 22(14_suppl). 6557–6557. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026